glaucoma surgery and cataract eye surgery  glaukos toggle navigation glaukos all at once im free cataract surgery and glaucoma therapy  all in one procedure implanted during cataract surgery istent® can help reduce your eye pressure and may reduce your reliance on glaucoma medication at the discretion of an eye care professional learn more about istent® important safety information » a tiny implanta huge impact istent® is not only the smallest medical implant known to be implanted in the human body – it also started a revolution in glaucoma surgery and treatment as the first microinvasive glaucoma surgery device the first migs device approved by the fda istent® has been implanted in over  eyes around the world see how istent® works important safety information » see glaucoma in a new light if you’ve been diagnosed with glaucoma don’t get discouraged get informed learn about your condition and understand just how much you still have to look forward to learn more with new treatment options the future is bright as healthcare advances you have access to more options to help treat and control your eye pressure associated with mildtomoderate openangle glaucoma learn about the range of options available – from using prescription eye drops to implanting the advanced istent® during cataract surgery – and decide which option may be best for you start today important safety information » speak with an istent® physician today help is right around the corner leading eye professionals across the country offer istent® for the treatment and control of eye pressure associated with mildtomoderate openangle glaucoma and are available to answer your questions find out if you are a candidate for istent® by talking with an istent® physician in your area today find an an istent® physician important safety information » about us mission  overview management team board of directors scientific advisory board news room healthcare professionals general info international contacts reimbursement login policies  info terms of use privacy policy declaration of compliance dfu  mri information careers contact us investors investor overview stock information financials corporate governance press releases events  presentations resources  alerts sign up for news  updates nameemail i am ai am apatienthealthcare professionalinvestment professionalothernamethis field is for validation purposes and should be left unchanged this iframe contains the logic required to handle ajax powered gravity forms sign up for investorrelated email alerts  » please select your country united statesaustraliacanadagermany continue × leaving the glaukoscom website you have just clicked a link that will take you outside of glaukoscom by clicking continue to outside site you will be taken to this is a website to which our privacy policy does not apply you are solely responsible for your interactions on outside websites continue to outside site cancel and stay here contact us  glaukos toggle navigation glaukos contact us i am apatienthealthcare professionalinvestment professionalotherfirst namelast nameemail phoneaddress line address line citystate  province  regionzip  postal codecountryafghanistanalbaniaalgeriaamerican samoaandorraangolaantigua and barbudaargentinaarmeniaaustraliaaustriaazerbaijanbahamasbahrainbangladeshbarbadosbelarusbelgiumbelizebeninbermudabhutanboliviabosnia and herzegovinabotswanabrazilbruneibulgariaburkina fasoburundicambodiacamerooncanadacape verdecayman islandscentral african republicchadchilechinacolombiacomoroscongo democratic republic of thecongo republic of thecosta ricacôte divoirecroatiacubacyprusczech republicdenmarkdjiboutidominicadominican republiceast timorecuadoregyptel salvadorequatorial guineaeritreaestoniaethiopiafaroe islandsfijifinlandfrancefrench polynesiagabongambiageorgiagermanyghanagreecegreenlandgrenadaguamguatemalaguineaguineabissauguyanahaitihondurashong konghungaryicelandindiaindonesiairaniraqirelandisraelitalyjamaicajapanjordankazakhstankenyakiribatinorth koreasouth koreakosovokuwaitkyrgyzstanlaoslatvialebanonlesotholiberialibyaliechtensteinlithuanialuxembourgmacedoniamadagascarmalawimalaysiamaldivesmalimaltamarshall islandsmauritaniamauritiusmexicomicronesiamoldovamonacomongoliamontenegromoroccomozambiquemyanmarnamibianaurunepalnetherlandsnew zealandnicaraguanigernigerianorthern mariana islandsnorwayomanpakistanpalaupalestine state ofpanamapapua new guineaparaguayperuphilippinespolandportugalpuerto ricoqatarromaniarussiarwandasaint kitts and nevissaint luciasaint vincent and the grenadinessamoasan marinosao tome and principesaudi arabiasenegalserbiaseychellessierra leonesingaporesint maartenslovakiasloveniasolomon islandssomaliasouth africaspainsri lankasudansudan southsurinameswazilandswedenswitzerlandsyriataiwantajikistantanzaniathailandtogotongatrinidad and tobagotunisiaturkeyturkmenistantuvaluugandaukraineunited arab emiratesunited kingdomunited statesuruguayuzbekistanvanuatuvatican cityvenezuelavietnamvirgin islands britishvirgin islands usyemenzambiazimbabwesubspecialtycataractanterior segmentglaucomacomprehensivecornearetinaothermessagemessage sign me up for important news  updates please have a representative contact me commentsthis field is for validation purposes and should be left unchanged this iframe contains the logic required to handle ajax powered gravity forms about us mission  overview management team board of directors scientific advisory board news room healthcare professionals general info international contacts reimbursement login policies  info terms of use privacy policy declaration of compliance dfu  mri information careers contact us investors investor overview stock information financials corporate governance press releases events  presentations resources  alerts sign up for news  updates nameemail i am ai am apatienthealthcare professionalinvestment professionalothernamethis field is for validation purposes and should be left unchanged this iframe contains the logic required to handle ajax powered gravity forms sign up for investorrelated email alerts  » please select your country united statesaustraliacanadagermany continue × leaving the glaukoscom website you have just clicked a link that will take you outside of glaukoscom by clicking continue to outside site you will be taken to this is a website to which our privacy policy does not apply you are solely responsible for your interactions on outside websites continue to outside site cancel and stay here the istent procedure for glaucoma treatment  glaukos toggle navigation glaukos the procedure envision cataract surgery and glaucoma therapy all in one procedure implanted during cataract surgery istent® can effectively lower iop one of the most important risk factors for glaucoma and may reduce your reliance on glaucoma medication at the discretion of an eye care professional learn more important safety information » how istent® works istent® can help to restore your eye’s natural fluid outflow and is designed to reduce pressure inside your eye learn more important safety information » a tiny medical implant istent’s® small design can bring big results in helping manage your eye pressure learn more important safety information » know what to expect with istent® learn what to expect before during and after your istent® procedure learn more speak with an istent® physician today help is right around the corner leading eye professionals across the country offer istent® for the treatment and control of eye pressure associated with mildtomoderate openangle glaucoma and are available to answer your questions find out if you are a candidate for istent® by talking with an istent® physician in your area today find an an istent® physician important safety information » about us mission  overview management team board of directors scientific advisory board news room healthcare professionals general info international contacts reimbursement login policies  info terms of use privacy policy declaration of compliance dfu  mri information careers contact us investors investor overview stock information financials corporate governance press releases events  presentations resources  alerts sign up for news  updates nameemail i am ai am apatienthealthcare professionalinvestment professionalothernamethis field is for validation purposes and should be left unchanged this iframe contains the logic required to handle ajax powered gravity forms sign up for investorrelated email alerts  » please select your country united statesaustraliacanadagermany continue × leaving the glaukoscom website you have just clicked a link that will take you outside of glaukoscom by clicking continue to outside site you will be taken to this is a website to which our privacy policy does not apply you are solely responsible for your interactions on outside websites continue to outside site cancel and stay here glaukos corporation  investors  investor overview toggle navigation login home»investors»investor overview login quick links email alerts contact ir rss feeds ethics hotline investor kit we are an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma one of the world’s leading causes of blindness we have pioneered microinvasive glaucoma surgery or migs to revolutionize the traditional glaucoma treatment and management paradigm we launched the istent® our first migs device in the united states in july  and we are leveraging our platform technology to build a comprehensive and proprietary portfolio of microscale injectable therapies designed to address the complete range of glaucoma disease states and progression we believe the istent® is the smallest medical device ever approved by the food and drug administration or fda measuring  mm long and  mm wide view stock information financials  filings access our filings with the securities and exchange commission sec via the link below these filings are also available at wwwsecgov view financials  filings latest press releases july   glaukos corporation to release second quarter  financial results after market close on august  june   combining implantation of glaukos istent inject® trabecular microbypass with topical travoprost provides sustained iop reduction and favorable safety profile according to new study may   glaukos announces participation in william blair growth stock conference view more press releases events  presentations access information about recent and upcoming investor events via the link below view events  presentations contact investor relations glaukos corporation  avenida fabricante san clemente ca  telephone  ext  fax  email investorsglaukoscom about us mission  overview management team board of directors scientific advisory board news room healthcare professionals general info international contacts reimbursement login policies  info terms of use  privacy policy  declaration of compliance  dfu  mri information investors investor overview stock information financials  filings corporate governance press releases events  presentations resources  alerts careers contact us investors mobile investor overview stock information financials  filings corporate governance press releases events  presentations resources  alerts healthcare professionals general info international contacts reimbursement login careers contact us glaukos® and istent® are registered trademarks of glaukos corporationall rights reserved  phone  fax   avenida fabricante san clemente ca  powered by q inc  dfu  mri information  glaukos toggle navigation glaukos dfu  mri information directions for use download dfu mri safety information nonclinical testing has demonstrated that the istent trabecular microbypass stent models gtsr and gtsl is mr conditional a patient with this device can be safely scanned in an mr system meeting the following conditions static magnetic field of t or less maximum spatial gradient magnetic field of  gausscm  tm maximum mr system reported whole body averaged specific absorption rate sar of  wkg first level controlled operating mode under the scan conditions defined above the istent trabecular microbypass stent models gtsr and gtsl is not expected to produce a clinically significant temperature rise after  minutes of continuous scanning in nonclinical testing the image artifact caused by the device extends less than  mm from the device when imaged with a gradient echo pulse sequence and a  t mri system about us mission  overview management team board of directors scientific advisory board news room healthcare professionals general info international contacts reimbursement login policies  info terms of use privacy policy declaration of compliance dfu  mri information careers contact us investors investor overview stock information financials corporate governance press releases events  presentations resources  alerts sign up for news  updates nameemail i am ai am apatienthealthcare professionalinvestment professionalothernamethis field is for validation purposes and should be left unchanged this iframe contains the logic required to handle ajax powered gravity forms sign up for investorrelated email alerts  » please select your country united statesaustraliacanadagermany continue × leaving the glaukoscom website you have just clicked a link that will take you outside of glaukoscom by clicking continue to outside site you will be taken to this is a website to which our privacy policy does not apply you are solely responsible for your interactions on outside websites continue to outside site cancel and stay here clinical data on istent surgery  glaukos toggle navigation glaukos clinical data istent® clinical data recent randomized controlled trials and case studies have shown that istent® is a procedure with limited complications and an excellent safety profile a recent independent international clinical study published by the journal of cataract and refractive surgery shows that istent® provided a  reduction in iop and an  reduction in the number of glaucoma medications three years following surgery reduced intraocular pressure iop the us ide pivotal study for istent® conducted by glaukos and reviewed by the fda was the first prospective randomized us ide trial for a glaucoma device this groundbreaking study showed that  of subjects in the istent® treatment group combined cataract and istent® implantation met the primary endpoint of iop ≤  mm hg with no medications at  months compared to only  of subjects in the cataract surgery group only this difference is statistically p   and clinically significant in a second independent month study  of patients who received istent® during a cataract procedure sustained target iops of ≤  mm hg   important safety information » reduction in glaucoma medication the ide pivotal trial additionally showed  of patients who received istent® remained medication free while sustaining a mean iop reduction of  versus only  who underwent cataract surgery alone p   in the independent month study noted previously  of patients who received istent® during a cataract procedure were able to stop taking their glaucoma medication after surgery   important safety information » safety for patients with combined cataract and openangle glaucoma istent® can reduce iop while maintaining an excellent safety profile the us ide pivotal study showed adverse events cataract surgery with istent® n n  cataract surgery only n n  early postop corneal edema     any bcva loss of at least  line at or after the  month visit     posterior capsular opacification     stent obstruction     blurry vision or visual disturbance     elevated iop     the istent® procedure spares conjunctival tissue and preserves the potential for future treatment options additionally there is minimal risk of hypotony with implantation of istent® because the trabecular meshwork is preserved ensuring a natural episcleral backpressure of  to  mm hg important safety information » looking for more information on istent® we’re here to answer questions and provide any additional information you may need contact us istent® integrating istent® into your practice about us mission  overview management team board of directors scientific advisory board news room healthcare professionals general info international contacts reimbursement login policies  info terms of use privacy policy declaration of compliance dfu  mri information careers contact us investors investor overview stock information financials corporate governance press releases events  presentations resources  alerts sign up for news  updates nameemail i am ai am apatienthealthcare professionalinvestment professionalothernamethis field is for validation purposes and should be left unchanged this iframe contains the logic required to handle ajax powered gravity forms sign up for investorrelated email alerts  » please select your country united statesaustraliacanadagermany continue × leaving the glaukoscom website you have just clicked a link that will take you outside of glaukoscom by clicking continue to outside site you will be taken to this is a website to which our privacy policy does not apply you are solely responsible for your interactions on outside websites continue to outside site cancel and stay here glaukos corp gkos  product pipeline analysis  update  new market research report  today july    am ﻿ home sign up new press release categories your current selected language is germanclick below to switsch to english ﻿ home sign up new press release categories ﻿ health glaukos corp gkos  product pipeline analysis  update  new market research report fast market research recommends glaukos corp gkos  product pipeline analysis  update from globaldata now available prinsidecom   glaukos corp glaukos is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy the company develops injectable microscale therapies to address the complete range of glaucoma disease states and progression its products include microstent devices to treat glaucoma such as istent trabecular microbypass stent for the treatment of mild tomoderate openangle glaucoma glaukos istent is used in conjunction with cataract surgery glaukos istent improves outflow by creating a patent bypass between the anterior chamber and schlemms canal the company markets its products through a network of distributors in germany italy canada portugal spain the uk and france glaukos is headquartered in san clemente california the us full report details at  wwwfastmrcomprodglaukoscorpgkosproductaspxafid  this report is a source for data analysis and actionable intelligence on the companys portfolio of pipeline products the report provides key information about the company its major products and brands the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage report scope  the report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developments  the report analyzes all pipeline products in development for the company glaukos corp  the report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial status  the report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch date  the report provides detailed description of products in development technical specification and functions  the report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end date reasons to get this report  develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape  design and develop your product development marketing and sales strategies by understanding the competitor portfolio  to formulate effective research  development strategies  develop marketentry and market expansion strategies  exploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust return  plan mergers and acquisitions effectively by identifying key players of the most promising pipeline  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials stage and of development etc  identify understand and capitalize the next highvalue products that your competitor would add in its portfolio note some sections may be missing if data is unavailable for the company companies mentioned in this report staar surgical company iridex corporation us cyberonics inc about globaldata globaldata is a leading provider of global business intelligence including market competitor product and customer information it provides indepth research analysis data and forecasts through a range of interactive online databases reports and management briefings globaldata has a large team of experienced research and analysis consulting and marketing experts it has a global presence including key offices in the us europe and asia the group has over  years of experience of delivering market intelligence data and analysis and a highly experienced senior management team view more research from globaldata at wwwfastmrcomcatalogpublishersaspxpubidafid about fast market research fast market research is a leading distributor of market research and business information representing the worlds top research publishers and analysts we provide quick and easy access to the best competitive intelligence available our unbiased expert staff is always available to help you find the right research to fit your requirements and your budget for more information about these or related research reports please visit our website at wwwfastmrcom or call us at   intl press information published bybill thompsonemail wwwfastmrcom   words related articles more from the authornew market report india radiosurgery market outlook globaldatas new report india radiosurgery market outlook to  provides key market data on the india radiosurgery market the icp intracranial pressure monitoring devices  medical globaldatas medical devices sector report icp intracranial pressure monitoring devices  medical devices pipeline assessment  wilms tumor protein wt or wt  wilms tumor protein wt or wt pipeline target constitutes close to  molecules out of which approximately  molecules are spinal cord stimulators  medical devices pipeline globaldatas medical devices sector report spinal cord stimulators  medical devices pipeline assessment  provides an global deception technology market   new deception technology was introduced as an advanced security feature to track and avoid targeted attacks deceptions are achieved  more from healthcla safflower oil diet review  does cla safflower oil is apparently something that many individuals are hyped about cla safflower oil can burn your fat away cla safflower oil is under review and the competition is mainly between two important brands and it is about how much more effective safflower oil is compared oyaco  home healthcare shoppe are coming oyaco has always been a trustworthy name among the parents the products that they sell are of the utmost quality plasma nutrition launches world’s first reducedcalorie protein people looking to lose weight or keep it under control can now add protein to their diet reduce daily calories eureka dental group inhouse laboratory in west while in the chair impressions can be made both physically and with computer modeling these are then expertly transferred to  disclaimer if you have any questions regarding information in this press release please contact the company added in the press release please do not contact prinside we will not be able to assist you prinside disclaims the content included in this release ﻿ gkos stock price  glaukos corp stock quote us nyse  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers ctas  cof  etfc  syf  hp  isrg  hban  chk  latest newsall times eastern  updated ‘game of thrones’ the four biggest takeaways from stormborn’  updated why you’re more likely to die in an accident during the summer months  updated these wealthy parents spend  for summer camps so their kids can be ‘normal’  updated  totally avoidable reasons why millennials can’t have nice things or save any money  updated how elon musk and shorter commutes could transform people’s lives  updated john mccain is a war hero — but think twice before saying he’s ‘battling’ cancer  updated the dark side of cruises  updated at least  dead after overheated tractortrailer found outside texas walmart  ‘full transparency’ doesn’t mean what scaramucci apparently thinks it means  stocks brace for volatility in earnings deluge fed meeting looms to be replaced home investing quotes stocks united states gkos overview compare quotes stock screener earnings calendar sectors nyse gkos us nyse join td ameritrade find a broker glaukos corp watchlist creategkosalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap b shares outstanding m public float m beta  rev per employee k pe ratio  eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones glaukos stock price target raised to  from  at stifel nicolaus feb   at  am et by tomi kilgore opinion investors rejoice us stocks are easily shaking off bad news feb   at  pm et by kevin marder dow industrials venture to lesscharted territory sp  holds the range jan   at  am et by michael ashbaugh opinion on second thought maybe the ‘trump rally’ has months left to run — and here’s why jan   at  am et by kevin marder glaukos upgraded to buy vs hold at stifel jan   at  am et by ciara linnane damage done to stocks means investors need to hit ‘pause’ sep   at  am et by kevin marder glaukos started at hold at stifel nicolaus apr   at  am et by tomi kilgore almost half of auditor warnings about potential failure are on ipos jan   at  am et by francine mckenna barrons bounce linn energy glaukos seagate apr   at  pm et on barrons skeptics eye potential trouble for glaukos apr   at  am et on barrons recent news other news press releases medtech thriving on consolidation  expansion stocks to buy the industry has some powerful longterm tailwinds of the medical device industry like mergers  acquisitions ma emerging market expansion positive demographic trends and new product innovation jul   at  pm et on zackscom glaukos istent lowered iop  in openangle glaucoma patients glaukos istent lowered iop  in openangle glaucoma patients jun   at  am et on seeking alpha  growth stocks for bold investors jun   at  pm et on motley fool can this  medical ipo inject new life into its stock on wednesday glaukos gkos got a positive adjustment to its relative strength rs rating from  to  this exclusive rating from investors business daily measures market leadership with a  worst to  best score the grade shows how a stocks price movement over the last  weeks stacks up against all the other stocks in our database decades of market research reveals that the best stocks tend to have an rs rating north of  in the may   at  am et on investors business daily glaukos gkos bank of america merrill lynch  health care conference  slideshow glaukos gkos bank of america merrill lynch  health care conference  slideshow may   at  pm et on seeking alpha cerner cern earnings and revenues beat estimates in q cerner corp cern reported adjusted firstquarter  earnings of  cents per share beating the zacks consensus estimate of  cents apr   at  am et on zackscom conmed cnmd q earnings surpass estimates increase yy conmed corporation cnmd reported firstquarter  adjusted earnings of  cents per share beating the zacks consensus estimate by  cents apr   at  am et on zackscom q glaukos corp q glaukos corp may   at  pm et on edgar online  edg  q k glaukos growth continues cantor reiterates overweight rating  target glaukos growth continues cantor reiterates overweight rating  target may   at  am et on benzingacom glaukos gkos ceo tom burns on q  results  earnings call transcript glaukos gkos ceo tom burns on q  results  earnings call transcript may   at  pm et on seeking alpha stryker syk earnings and revenues beat estimates in q stryker corp syk reported adjusted earnings of  per share in the first quarter of  which comfortably beat the zacks consensus estimate by  cents apr   at  am et on zackscom notable earnings after wednesday’s close notable earnings after wednesday’s close may   at  pm et on seeking alpha cerner cern earnings and revenues beat estimates in q apr   at  am et on zackscom conmed cnmd q earnings surpass estimates increase yy apr   at  am et on zackscom stryker syk earnings and revenues beat estimates in q apr   at  am et on zackscom baron opportunity fund comments on glaukos corp apr   at  pm et on gurufocuscom baron opportunity fund first quarter  shareholder letter apr   at  pm et on gurufocuscom why apogee enterprises embraer and glaukos slumped today apr   at  pm et on motley fool glaukos dives to month low on proposal to slash reimbursements apr   at  pm et on investors business daily glaukos likely to overturn istent rate cut by noridian  wells fargo apr   at  am et on seeking alpha glaukos corporation to release second quarter  financial results after market close on august  glaukos corporation to release second quarter  financial results after market close on august  jul   at  am et on businesswire  bzx todays research report coverage on medical supplies stocks  orasure technologies dentsply sirona baxter intl and glaukos todays research report coverage on medical supplies stocks  orasure technologies dentsply sirona baxter intl and glaukos jul   at  am et on pr newswire  prf combining implantation of glaukos istent inject® trabecular microbypass with topical travoprost provides sustained iop reduction and favorable safety profile according to new study combining implantation of glaukos istent inject® trabecular microbypass with topical travoprost provides sustained iop reduction and favorable safety profile according to new study jun   at  am et on businesswire  bzx glaukos announces participation in william blair growth stock conference glaukos announces participation in william blair growth stock conference may   at  pm et on businesswire  bzx study reveals potential cost efficiency of using two glaukos istent® trabecular microbypass stents to treat elevated iop in glaucoma patients study reveals potential cost efficiency of using two glaukos istent® trabecular microbypass stents to treat elevated iop in glaucoma patients may   at  pm et on businesswire  bzx medical supplies stocks on investors radar  baxter dentsply sirona orasure technologies and glaukos medical supplies stocks on investors radar  baxter dentsply sirona orasure technologies and glaukos may   at  am et on pr newswire  prf glaukos corporation announces first quarter  financial results glaukos corporation announces first quarter  financial results may   at  pm et on businesswire  bzx glaukos completes patient enrollment in phase ii clinical trial for idose™ travoprost intraocular implant in glaucoma patients glaukos completes patient enrollment in phase ii clinical trial for idose™ travoprost intraocular implant in glaucoma patients may   at  am et on businesswire  bzx glaukos announces participation in bank of america merrill lynch  health care conference glaukos announces participation in bank of america merrill lynch  health care conference may   at  am et on businesswire  bzx glaukos corporation to release first quarter  financial results after market close on may  apr   at  am et on businesswire  bzx international study shows two glaukos istent® trabecular microbypass stents and one topical medication deliver sustained iop reduction apr   at  am et on businesswire  bzx glaukos corporation acquires iop sensor system from dose medical apr   at  pm et on businesswire  bzx research reports initiation on medical supplies stocks  orasure technologies transenterix glaukos and tandem diabetes apr   at  am et on pr newswire  prf glaukos announces fiveyear extensions for three category iii cpt codes related to microinvasive glaucoma surgery mar   at  am et on businesswire  bzx glaukos corporation announces fourth quarter  full year  financial results mar   at  pm et on businesswire  bzx glaukos technologies featured in eight presentations at  american glaucoma society meeting feb   at  pm et on businesswire  bzx glaukos announces participation in th annual roth conference feb   at  am et on businesswire  bzx how these medical instruments stocks are faring  tandem diabetes care c r bard glaukos and orasure technologies feb   at  am et on pr newswire  prf preeminent ophthalmologist l jay katz joins glaukos corporation as chief medical officer feb   at  am et on businesswire  bzx glaukos completes patient enrollment in pivotal phase of us ide clinical trial for istent supra® feb   at  am et on businesswire  bzx glaukos corp glaukos corp is an ophthalmic medical device company which engages in the development and commercialization of products and procedures designed to transform the treatment of glaucoma its micro invasive glaucoma surgery procedures are designed to reduce intraocular eye pressure by improving aqueous outflow through the natural physiologic pathway the company was founded by olav b bergheim morteza gharib and richard hill in july  and is headquartered in san clemente ca see full profile analyst ratings sell under hold over buy number of ratings  full ratings glaukos growth continues cantor reiterates overweight rating  target may   at  am et on benzingacom benzingas top initiations oct   at  am et on benzingacom glaukos way ahead of the glaucoma competition sep   at  pm et on benzingacom competitors name chg  market cap integra lifesciences holdings corp  b icu medical inc  b atricure inc  m boston scientific corp  b competitor data provided by partner content trending tickers powered by bzun  googl  ugaz  nyt  mrk  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience stocks index  markets index bulletin investor alert tokyo markets close in currencies europe markets london markets stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pif you suddenly quit your job like sean spicer here’s what you should do next pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders pbanks have raised creditcard interest rates — but not savings account rates aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert tokyo markets close in currencies europe markets london markets stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pif you suddenly quit your job like sean spicer here’s what you should do next pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders pbanks have raised creditcard interest rates — but not savings account rates aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert tokyo markets close in currencies europe markets london markets stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pif you suddenly quit your job like sean spicer here’s what you should do next pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders pbanks have raised creditcard interest rates — but not savings account rates aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  gkos stock price  glaukos corp stock quote us nyse  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers ctas  cof  etfc  syf  hp  isrg  hban  chk  latest newsall times eastern  updated ‘game of thrones’ the four biggest takeaways from stormborn’  updated why you’re more likely to die in an accident during the summer months  updated these wealthy parents spend  for summer camps so their kids can be ‘normal’  updated  totally avoidable reasons why millennials can’t have nice things or save any money  updated how elon musk and shorter commutes could transform people’s lives  updated john mccain is a war hero — but think twice before saying he’s ‘battling’ cancer  updated the dark side of cruises  updated at least  dead after overheated tractortrailer found outside texas walmart  ‘full transparency’ doesn’t mean what scaramucci apparently thinks it means  stocks brace for volatility in earnings deluge fed meeting looms to be replaced home investing quotes stocks united states gkos overview compare quotes stock screener earnings calendar sectors nyse gkos us nyse join td ameritrade find a broker glaukos corp watchlist creategkosalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap b shares outstanding m public float m beta  rev per employee k pe ratio  eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones glaukos stock price target raised to  from  at stifel nicolaus feb   at  am et by tomi kilgore opinion investors rejoice us stocks are easily shaking off bad news feb   at  pm et by kevin marder dow industrials venture to lesscharted territory sp  holds the range jan   at  am et by michael ashbaugh opinion on second thought maybe the ‘trump rally’ has months left to run — and here’s why jan   at  am et by kevin marder glaukos upgraded to buy vs hold at stifel jan   at  am et by ciara linnane damage done to stocks means investors need to hit ‘pause’ sep   at  am et by kevin marder glaukos started at hold at stifel nicolaus apr   at  am et by tomi kilgore almost half of auditor warnings about potential failure are on ipos jan   at  am et by francine mckenna barrons bounce linn energy glaukos seagate apr   at  pm et on barrons skeptics eye potential trouble for glaukos apr   at  am et on barrons recent news other news press releases medtech thriving on consolidation  expansion stocks to buy the industry has some powerful longterm tailwinds of the medical device industry like mergers  acquisitions ma emerging market expansion positive demographic trends and new product innovation jul   at  pm et on zackscom glaukos istent lowered iop  in openangle glaucoma patients glaukos istent lowered iop  in openangle glaucoma patients jun   at  am et on seeking alpha  growth stocks for bold investors jun   at  pm et on motley fool can this  medical ipo inject new life into its stock on wednesday glaukos gkos got a positive adjustment to its relative strength rs rating from  to  this exclusive rating from investors business daily measures market leadership with a  worst to  best score the grade shows how a stocks price movement over the last  weeks stacks up against all the other stocks in our database decades of market research reveals that the best stocks tend to have an rs rating north of  in the may   at  am et on investors business daily glaukos gkos bank of america merrill lynch  health care conference  slideshow glaukos gkos bank of america merrill lynch  health care conference  slideshow may   at  pm et on seeking alpha cerner cern earnings and revenues beat estimates in q cerner corp cern reported adjusted firstquarter  earnings of  cents per share beating the zacks consensus estimate of  cents apr   at  am et on zackscom conmed cnmd q earnings surpass estimates increase yy conmed corporation cnmd reported firstquarter  adjusted earnings of  cents per share beating the zacks consensus estimate by  cents apr   at  am et on zackscom q glaukos corp q glaukos corp may   at  pm et on edgar online  edg  q k glaukos growth continues cantor reiterates overweight rating  target glaukos growth continues cantor reiterates overweight rating  target may   at  am et on benzingacom glaukos gkos ceo tom burns on q  results  earnings call transcript glaukos gkos ceo tom burns on q  results  earnings call transcript may   at  pm et on seeking alpha stryker syk earnings and revenues beat estimates in q stryker corp syk reported adjusted earnings of  per share in the first quarter of  which comfortably beat the zacks consensus estimate by  cents apr   at  am et on zackscom notable earnings after wednesday’s close notable earnings after wednesday’s close may   at  pm et on seeking alpha cerner cern earnings and revenues beat estimates in q apr   at  am et on zackscom conmed cnmd q earnings surpass estimates increase yy apr   at  am et on zackscom stryker syk earnings and revenues beat estimates in q apr   at  am et on zackscom baron opportunity fund comments on glaukos corp apr   at  pm et on gurufocuscom baron opportunity fund first quarter  shareholder letter apr   at  pm et on gurufocuscom why apogee enterprises embraer and glaukos slumped today apr   at  pm et on motley fool glaukos dives to month low on proposal to slash reimbursements apr   at  pm et on investors business daily glaukos likely to overturn istent rate cut by noridian  wells fargo apr   at  am et on seeking alpha glaukos corporation to release second quarter  financial results after market close on august  glaukos corporation to release second quarter  financial results after market close on august  jul   at  am et on businesswire  bzx todays research report coverage on medical supplies stocks  orasure technologies dentsply sirona baxter intl and glaukos todays research report coverage on medical supplies stocks  orasure technologies dentsply sirona baxter intl and glaukos jul   at  am et on pr newswire  prf combining implantation of glaukos istent inject® trabecular microbypass with topical travoprost provides sustained iop reduction and favorable safety profile according to new study combining implantation of glaukos istent inject® trabecular microbypass with topical travoprost provides sustained iop reduction and favorable safety profile according to new study jun   at  am et on businesswire  bzx glaukos announces participation in william blair growth stock conference glaukos announces participation in william blair growth stock conference may   at  pm et on businesswire  bzx study reveals potential cost efficiency of using two glaukos istent® trabecular microbypass stents to treat elevated iop in glaucoma patients study reveals potential cost efficiency of using two glaukos istent® trabecular microbypass stents to treat elevated iop in glaucoma patients may   at  pm et on businesswire  bzx medical supplies stocks on investors radar  baxter dentsply sirona orasure technologies and glaukos medical supplies stocks on investors radar  baxter dentsply sirona orasure technologies and glaukos may   at  am et on pr newswire  prf glaukos corporation announces first quarter  financial results glaukos corporation announces first quarter  financial results may   at  pm et on businesswire  bzx glaukos completes patient enrollment in phase ii clinical trial for idose™ travoprost intraocular implant in glaucoma patients glaukos completes patient enrollment in phase ii clinical trial for idose™ travoprost intraocular implant in glaucoma patients may   at  am et on businesswire  bzx glaukos announces participation in bank of america merrill lynch  health care conference glaukos announces participation in bank of america merrill lynch  health care conference may   at  am et on businesswire  bzx glaukos corporation to release first quarter  financial results after market close on may  apr   at  am et on businesswire  bzx international study shows two glaukos istent® trabecular microbypass stents and one topical medication deliver sustained iop reduction apr   at  am et on businesswire  bzx glaukos corporation acquires iop sensor system from dose medical apr   at  pm et on businesswire  bzx research reports initiation on medical supplies stocks  orasure technologies transenterix glaukos and tandem diabetes apr   at  am et on pr newswire  prf glaukos announces fiveyear extensions for three category iii cpt codes related to microinvasive glaucoma surgery mar   at  am et on businesswire  bzx glaukos corporation announces fourth quarter  full year  financial results mar   at  pm et on businesswire  bzx glaukos technologies featured in eight presentations at  american glaucoma society meeting feb   at  pm et on businesswire  bzx glaukos announces participation in th annual roth conference feb   at  am et on businesswire  bzx how these medical instruments stocks are faring  tandem diabetes care c r bard glaukos and orasure technologies feb   at  am et on pr newswire  prf preeminent ophthalmologist l jay katz joins glaukos corporation as chief medical officer feb   at  am et on businesswire  bzx glaukos completes patient enrollment in pivotal phase of us ide clinical trial for istent supra® feb   at  am et on businesswire  bzx glaukos corp glaukos corp is an ophthalmic medical device company which engages in the development and commercialization of products and procedures designed to transform the treatment of glaucoma its micro invasive glaucoma surgery procedures are designed to reduce intraocular eye pressure by improving aqueous outflow through the natural physiologic pathway the company was founded by olav b bergheim morteza gharib and richard hill in july  and is headquartered in san clemente ca see full profile analyst ratings sell under hold over buy number of ratings  full ratings glaukos growth continues cantor reiterates overweight rating  target may   at  am et on benzingacom benzingas top initiations oct   at  am et on benzingacom glaukos way ahead of the glaucoma competition sep   at  pm et on benzingacom competitors name chg  market cap integra lifesciences holdings corp  b icu medical inc  b atricure inc  m boston scientific corp  b competitor data provided by partner content trending tickers powered by bzun  googl  ugaz  nyt  mrk  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience about us  glaukos toggle navigation glaukos about us mission statement our mission is to pioneer and lead the global glaucoma market with microscale injectable therapies that advance the existing glaucoma standardofcare and enrich the lives and treatment alternatives for glaucoma patients worldwide corporate overview glaukos corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma one of the world’s leading causes of blindness we have pioneered microinvasive glaucoma surgery or migs in order to revolutionize the traditional glaucoma treatment and management paradigm we launched the istent® our first migs device in the united states in  we are leveraging our platform technology to build a comprehensive and proprietary portfolio of injectable microscale therapies designed to address the complete range of glaucoma disease states and progression we believe the istent® is the smallest medical device ever approved by the food and drug administration or fda measuring  mm long and  mm wide in june  we completed an initial public offering and our shares are now traded on the new york stock exchange under the ticker symbol “gkos” the company was founded in  and is based in san clemente california about us mission  overview management team board of directors scientific advisory board news room healthcare professionals general info international contacts reimbursement login policies  info terms of use privacy policy declaration of compliance dfu  mri information careers contact us investors investor overview stock information financials corporate governance press releases events  presentations resources  alerts sign up for news  updates nameemail i am ai am apatienthealthcare professionalinvestment professionalothernamethis field is for validation purposes and should be left unchanged this iframe contains the logic required to handle ajax powered gravity forms sign up for investorrelated email alerts  » please select your country united statesaustraliacanadagermany continue × leaving the glaukoscom website you have just clicked a link that will take you outside of glaukoscom by clicking continue to outside site you will be taken to this is a website to which our privacy policy does not apply you are solely responsible for your interactions on outside websites continue to outside site cancel and stay here glaukos corp gkos  product pipeline analysis  update by globaldata market research report at marketreportsonlinecom welcome guest  register  login      salesmarketreportsonlinecom home  medical devices  report detail glaukos corp gkos  product pipeline analysis  update report description table of contents faqs summary glaukos corp glaukos is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy the company develops injectable microscale therapies to address the complete range of glaucoma disease states and progression its products include microstent devices to treat glaucoma such as istent trabecular microbypass stent for the treatment of mild tomoderate openangle glaucoma glaukos istent is used in conjunction with cataract surgery glaukos istent improves outflow by creating a patent bypass between the anterior chamber and schlemms canal the company markets its products through a network of distributors in germany italy canada portugal spain the uk and france glaukos is headquartered in san clemente california the us this report is a source for data analysis and actionable intelligence on the companys portfolio of pipeline products the report provides key information about the company its major products and brands the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage scope  the report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developments  the report analyzes all pipeline products in development for the company glaukos corp  the report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial status  the report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch date  the report provides detailed description of products in development technical specification and functions  the report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end date reasons to buy  develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape  design and develop your product development marketing and sales strategies by understanding the competitor portfolio  to formulate effective research  development strategies  develop marketentry and market expansion strategies  exploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust return  plan mergers and acquisitions effectively by identifying key players of the most promising pipeline  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials stage and of development etc  identify understand and capitalize the next highvalue products that your competitor would add in its portfolio note some sections may be missing if data is unavailable for the company single user license report will be emailed in pdf format and can be accessed by a specific user this license type allows the report to be printed site license report will be emailed in pdf and  allows only employees within the same geographical location within the organization to access it this license type allows the report to be printed global site license report will be emailed in pdf format and allows all employees within the organization to access it  this license type allows the report to be printed why httpwwwmarketreportsonlinecom glaukos corp gkos  product pipeline analysis  update published by globaldata price single user license us   site license us   global site license us   how to purchase purchase reports from our site in few easy clicks please follow the description given below to complete your purchase process step  select the report title of your interest and click on buy now button next to the price option step  you will arrive at the purchase page where you will be requested to signup new user or login registered user please note that inkeeping with the security check on the website you must submit your full details to avoid any inconvenience arising from incorrectly entered data or counterfeit information step  after signuplogin you will arrive at our payment page on paypal you will see your order summary as well as an option to choose a way to pay select a payment option from pay with a paypal account or pay with a debit or credit card marketreportonline accepts visa mastercard american express and discover through paypal fill up the required details in the option of your choice step  once you follow the required process in step  as mentioned above you have successfully completed the purchase process step  once you have successfully completed the purchase process you will receive a confirmation email the report will then be emailed to you directly by the publisher as per our agreement with the publisher for orders that are placed after working hours the delivery of the reports will be made on the next business day for orders that are placed during weekends the delivery of the reports will be made on the next working business day please note if you select purchase by invoice you will receive your report only once the payment has been received if you have any queries about how to order please contact us price  single user license us   site license us   global site license us   published may  no of pages  subscription option using our subscription option you get access to market research reports and industry data of medical devices market as per your needs get the best of medical devices research reports by utilizing your research budgets in an optimum way contact salesmarketreportsonlinecom for details email alert get email alerts about market research reports from industries and publishers of your interest market insights top banking trends the current trend include some of the key trends from last year with new trends in the areas of customer experience digital and mobile delivery digital payments innovation alternative products auth global tea market propelled by high green and black tea demands tea is the most popular beverages consumed globally the biggest share of tea consumption is mostly local in the country or region of production the tea industry is characterized by a few corporations monitoring the comp telehealth is the biggest revolution in healthcare telehealth is a very effectual way to consume medical care and it is bound for growth over time telehealth services expenditure in the us is estimated to catapult nearly ten times in the coming years forecasts are that  glaukos corp gkos  product pipeline analysis  update updated  the business research store the business research store × latest market research reports search by topic featured publishers become a partner special offers contact us  glaukos corp gkos  product pipeline analysis  update updated  single user price   single user price  glaukos corp gkos  product pipeline analysis  update updated  site license price   site license price  glaukos corp gkos  product pipeline analysis  update updated  enterprise license price   enterprise license price glaukos corp gkos  product pipeline analysis  update updated  published by global data  may     in stocksummaryglaukos corp glaukos is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy the company develops injectable microscale therapies to address the complete range of glaucoma disease states and progression its products include microstent devices to treat glaucoma such as istent trabecular microbypass stent for the treatment of mild tomoderate openangle glaucoma glaukos’ istent is used in conjunction with cataract surgery glauko’s istent improves outflow by creating a patent bypass between the anterior chamber and schlemm’s canal the company markets its products through a network of distributors in germany italy canada portugal spain the uk and france glaukos is headquartered in san clemente california the usthis report is a source for data analysis and actionable intelligence on the company’s portfolio of pipeline products the report provides key information about the company its major products and brands the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantagescope the report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developments the report analyzes all pipeline products in development for the company glaukos corp the report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial status the report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch date the report provides detailed description of products in development technical specification and functions the report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end datereasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape design and develop your product development marketing and sales strategies by understanding the competitor portfolio to formulate effective research  development strategies develop marketentry and market expansion strategies exploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust return plan mergers and acquisitions effectively by identifying key players of the most promising pipeline  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials stage and of development etc identify understand and capitalize the next highvalue products that your competitor would add in its portfolionote some sections may be missing if data is unavailable for the company  glaukos corp gkos  product pipeline analysis  update updated  single user price   single user price  glaukos corp gkos  product pipeline analysis  update updated  site license price   site license price  glaukos corp gkos  product pipeline analysis  update updated  enterprise license price   enterprise license price introductionsummaryglaukos corp glaukos is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy the company develops injectable microscale therapies to address the complete range of glaucoma disease states and progression its products include microstent devices to treat glaucoma such as istent trabecular microbypass stent for the treatment of mild tomoderate openangle glaucoma glaukos’ istent is used in conjunction with cataract surgery glauko’s istent improves outflow by creating a patent bypass between the anterior chamber and schlemm’s canal the company markets its products through a network of distributors in germany italy canada portugal spain the uk and france glaukos is headquartered in san clemente california the usthis report is a source for data analysis and actionable intelligence on the company’s portfolio of pipeline products the report provides key information about the company its major products and brands the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantagescope the report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developments the report analyzes all pipeline products in development for the company glaukos corp the report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial status the report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch date the report provides detailed description of products in development technical specification and functions the report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end datereasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape design and develop your product development marketing and sales strategies by understanding the competitor portfolio to formulate effective research  development strategies develop marketentry and market expansion strategies exploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust return plan mergers and acquisitions effectively by identifying key players of the most promising pipeline  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials stage and of development etc identify understand and capitalize the next highvalue products that your competitor would add in its portfolionote some sections may be missing if data is unavailable for the companytable of contentstable of contents table of contents list of tables list of figures glaukos corp company overview glaukos corp company snapshot glaukos corp pipeline products and ongoing clinical trials overview glaukos corp – pipeline analysis overview glaukos corp  key facts glaukos corp  major products and services glaukos corp pipeline products by development stage glaukos corp ongoing clinical trials by trial status glaukos corp pipeline products overview gts gts product overview idose travoprost intraocular implant idose travoprost intraocular implant product overview idose travoprost intraocular implant clinical trial iop sensor system iop sensor system product overview istent inject  cataract surgery istent inject  cataract surgery product overview istent inject  cataract surgery clinical trial istent inject  standalone procedures istent inject  standalone procedures product overview istent inject  standalone procedures clinical trial istent supra suprachoroidal microbypass stent istent supra suprachoroidal microbypass stent product overview istent supra suprachoroidal microbypass stent clinical trial glaukos corp  key competitors glaukos corp  key employees glaukos corp  locations and subsidiaries head office other locations  subsidiaries recent developments glaukos corp recent developments may   glaukos announces first quarter  financial results may   glaukos completes patient enrollment in phase ii clinical trial for idose travoprost intraocular implant in glaucoma patients may   several surgeon presentations to include glaukos technologies at  american society of cataract and refractive surgery may   several surgeon presentations to include glaukos technologies at  american society of cataract and refractive surgery apr   international study shows two glaukos istent trabecular microbypass stents and one topical medication deliver sustained iop reduction mar   glaukos announces fiveyear extensions for three category iii cpt codes related to microinvasive glaucoma surgery mar   glaukos announces fourth quarter  full year  financial results feb   glaukos technologies featured in eight presentations at  american glaucoma society meeting feb   preeminent ophthalmologist l jay katz joins glaukos as chief medical officer feb   glaukos completes patient enrollment in pivotal phase of us ide clinical trial for istent supra appendix methodology about globaldata contact us disclaimer list of tables in glaukos corp gkos  product pipeline analysis  update updated list of tables glaukos corp pipeline products and ongoing clinical trials overview glaukos corp pipeline products by equipment type glaukos corp pipeline products by indication glaukos corp ongoing clinical trials by trial status glaukos corp key facts glaukos corp major products and services glaukos corp number of pipeline products by development stage glaukos corp pipeline products summary by development stage glaukos corp ongoing clinical trials by trial status glaukos corp ongoing clinical trials summary gts  product status gts  product description idose travoprost intraocular implant  product status idose travoprost intraocular implant  product description idose travoprost intraocular implant  assessment of idose delivery systems safety and preliminary efficacy for the reduction of elevated intraocular pressure iop sensor system  product status iop sensor system  product description istent inject  cataract surgery  product status istent inject  cataract surgery  product description istent inject  cataract surgery  a prospective randomized evaluation of subjects with openangle glaucoma pseudoexfoliative glaucoma or ocular hypertension naïve to medical and surgical therapy treated with two trabecular microbypass stents istent inject or travoprost ophthalmic solution  istent inject  cataract surgery  a prospective randomized singlemasked controlled parallel groups multicenter clinical investigation of the glaukos trabecular microbypass stent model gts using the gmis injector system in conjunction with cataract surgery istent inject  cataract surgery  a randomized controlled trial of cataract surgery versus combined cataract surgery with insertion of istent inject istent inject  standalone procedures  product status istent inject  standalone procedures  product description istent inject  standalone procedures  a prospective evaluation of openangle glaucoma subjects on one topical hypotensive medication prostaglandin treated with two trabecular microbypass stents istent inject istent inject  standalone procedures  a prospective evaluation of openangle glaucoma subjects on two topical hypotensive medications one a prostaglandin treated with two trabecular microbypass stents istent inject and a postoperative topical prostaglandin istent inject  standalone procedures  initial phase of us ide clinical trial for standalone version of istent inject istent inject  standalone procedures  the effect of glaucoma surgery on aqueous dynamics in patients with glaucoma or ocular hypertension an observational study istent supra suprachoroidal microbypass stent  product status istent supra suprachoroidal microbypass stent  product description istent supra suprachoroidal microbypass stent  a prospective evaluation of openangle glaucoma subjects on two topical hypotensive medication treated with one suprachoroidal stent istent supra suprachoroidal microbypass stent  a prospective evaluation of openangle glaucoma subjects with one prior trabeculectomy treated concurrently with one suprachoroidal stent and two trabecular microbypass stents and a postoperative prostaglandin istent supra suprachoroidal microbypass stent  a prospective randomized singlemasked controlled parallel groups multicenter clinical investigation of the glaukos suprachoroidal stent model g in conjunction with cataract surgery glaukos corp key employees glaukos corp subsidiaries glossary list of figures charts and diagrams in glaukos corp gkos  product pipeline analysis  update updated list of figures glaukos corp pipeline products by equipment type glaukos corp pipeline products by development stage glaukos corp ongoing clinical trials by trial status additional detailspublisherglobal datapublisher informationreference  gdmepdnumber of pagesreport formatpdfrelated reportstitledate publishedprice frommore details glaukos corp gkos  medical equipment  deals and alliances profilesummaryglaukos corp glaukos is an ophthalmic medical device company that research and develops mic jul  by global data usd  more info glaukos corp gkos  medical equipment  deals and alliances profilesummaryglaukos corp glaukos is an ophthalmic medical device company that research and develops mic jun  by global data usd  more info glaukos corp gkos  financial and strategic swot analysis reviewsummaryglaukos corp glaukos is an ophthalmic medical device company that research and develops mic may  by global data usd  more info glaukos corp gkos  medical equipment  deals and alliances profilesummaryglaukos corp glaukos is an ophthalmic medical device company that research and develops mic jan  by global data usd  more info glaukos corporation company profile outlook business segments competitors goods and services swot and financial analysis“glaukos corporation company profile” is a complete analysis of the company’s operations strategie nov  by o g analysis usd  more info glaukos corporation gkos  medical equipment  deals and alliances profilesummaryglaukos corporation glaukos is an ophthalmic medical device company that research and devel nov  by global data usd  more info this report is published by global data download free report summary pdfdownload our free report summary pdf it contains all the information on these web pages plus a proforma invoice request form should you need it to satisfy your companys internal order proceduresordering informationorders are processed immediately and you will be notified of the despatch date on confirmation of your orderaccepted card types buy now using our secure payment system we stock download our free report summary pdfdownload our free report summary pdf it contains all the information on these web pages plus a proforma invoice request form should you need it to satisfy your companys internal order procedures× best price pdf sample  glaukos corp gkos  product pipeline analysis  update updated  single user price   single user price  glaukos corp gkos  product pipeline analysis  update updated  site license price   site license price  glaukos corp gkos  product pipeline analysis  update updated  enterprise license price   enterprise license price buy buy this report now  glaukos corp gkos  product pipeline analysis  update updated  single user price   single user price  glaukos corp gkos  product pipeline analysis  update updated  site license price   site license price  glaukos corp gkos  product pipeline analysis  update updated  enterprise license price   enterprise license price × gkos key statistics  glaukos corp financial ratios  marketwatch bulletin investor alert tokyo markets close in currencies europe markets london markets expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close glaukos corp nyse gkos go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus glaukos corp after hours  quotes are delayed by  min jul    pm gkos quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description glaukos corp is an ophthalmic medical device company which engages in the development and commercialization of products and procedures designed to transform the treatment of glaucoma its micro invasive glaucoma surgery procedures are designed to reduce intraocular eye pressure by improving aqueou glaukos corp is an ophthalmic medical device company which engages in the development and commercialization of products and procedures designed to transform the treatment of glaucoma its micro invasive glaucoma surgery procedures are designed to reduce intraocular eye pressure by improving aqueous outflow through the natural physiologic pathway the company was founded by olav b bergheim morteza gharib and richard hill in july  and is headquartered in san clemente ca valuation pe current  pe ratio with extraordinary items  pe ratio without extraordinary items  price to sales ratio  price to book ratio  price to cash flow ratio  enterprise value to ebitda  enterprise value to sales  efficiency revenueemployee  income per employee  receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability gross margin  operating margin  pretax margin  net margin  return on assets  return on equity  return on total capital  return on invested capital  capital structure officers and executives name age officer since title mr thomas william burns   president chief executive officer  director mr chris m calcaterra   chief operating officer mr joseph e gilliam   cfo  senior vpcorporate development dr l jay katz   chief medical officer mr robert l davis   secretary senior vice president  general counsel insider actions – purchase – sale  – number of transactions  date name shares transaction value  joseph e gilliam cfo svp corporate development    award at  per share   orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   william j link director      william j link director      orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   orbimed advisors llc director    disposition at  per share   thomas william burns chief executive officer director    disposition at  per share   chris m calcaterra chief commercial officer    disposition at  per share   richard l harrison cfo  treasurer    disposition at  per share   chris m calcaterra chief commercial officer    derivativenonderivative trans at  per share   richard l harrison cfo  treasurer    derivativenonderivative trans at  per share   chris m calcaterra chief commercial officer    disposition at  per share   richard l harrison cfo  treasurer    disposition at  per share   chris m calcaterra chief commercial officer    derivativenonderivative trans at  per share   richard l harrison cfo  treasurer    derivativenonderivative trans at  per share  newslatestcompanyusgkos marketwatch news on gkos glaukos stock price target raised to  from  at stifel nicolaus  am feb    tomi kilgore investors rejoice us stocks are easily shaking off bad news  pm feb    kevin marder dow industrials venture to lesscharted territory sp  holds the range  pm jan    michael ashbaugh on second thought maybe the ‘trump rally’ has months left to run — and here’s why  pm jan    kevin marder glaukos upgraded to buy vs hold at stifel  am jan    ciara linnane damage done to stocks means investors need to hit ‘pause’  am sept    the trading deck glaukos started at hold at stifel nicolaus  am april    tomi kilgore almost half of auditor warnings about potential failure are on ipos  pm jan    francine mckenna newsnonmarketwatchcompanyusgkos other news on gkos medtech thriving on consolidation  expansion stocks to buy  pm july    zackscom glaukos istent lowered iop  in openangle glaucoma patients  am june    seeking alpha  growth stocks for bold investors  pm june    motley fool can this  medical ipo inject new life into its stock  am may    investors business daily glaukos gkos bank of america merrill lynch  health care conference  slideshow  pm may    seeking alpha q glaukos corp  pm may    edgar online  edg  q k glaukos gkos ceo tom burns on q  results  earnings call transcript  pm may    seeking alpha notable earnings after wednesday’s close  pm may    seeking alpha cerner cern earnings and revenues beat estimates in q  am april    zackscom conmed cnmd q earnings surpass estimates increase yy  am april    zackscom stryker syk earnings and revenues beat estimates in q  am april    zackscom baron opportunity fund comments on glaukos corp  pm april    gurufocuscom baron opportunity fund first quarter  shareholder letter  pm april    gurufocuscom why apogee enterprises embraer and glaukos slumped today  pm april    motley fool glaukos dives to month low on proposal to slash reimbursements  pm april    investors business daily glaukos likely to overturn istent rate cut by noridian  wells fargo  am april    seeking alpha glaukos istent lowers longterm iop in glaucoma patients in international study  am april    seeking alpha  stocks that are overvalued  am april    motley fool wall street breakfast investors assess geopolitical risk  am april    seeking alpha biotech forum daily digest whats next for dynavax akorn on the block  am april    seeking alpha loading more headlines at a glance glaukos corp  avenida fabricante san clemente california  phone   industry medical equipmentsupplies sector health carelife sciences fiscal yearend  view sec filings revenue m net income m  sales growth  employees  annual report for gkos newspressreleasecompanyusgkos press releases on gkos glaukos corporation to release second quarter  financial results after market close on august   am july    businesswire  bzx todays research report coverage on medical supplies stocks  orasure technologies dentsply sirona baxter intl and glaukos  am july    pr newswire  prf combining implantation of glaukos istent inject® trabecular microbypass with topical travoprost provides sustained iop reduction and favorable safety profile according to new study  am june    businesswire  bzx glaukos announces participation in william blair growth stock conference  pm may    businesswire  bzx study reveals potential cost efficiency of using two glaukos istent® trabecular microbypass stents to treat elevated iop in glaucoma patients  pm may    businesswire  bzx medical supplies stocks on investors radar  baxter dentsply sirona orasure technologies and glaukos  am may    pr newswire  prf glaukos corporation announces first quarter  financial results  pm may    businesswire  bzx glaukos completes patient enrollment in phase ii clinical trial for idose™ travoprost intraocular implant in glaucoma patients  am may    businesswire  bzx glaukos announces participation in bank of america merrill lynch  health care conference  am may    businesswire  bzx glaukos corporation to release first quarter  financial results after market close on may   am april    businesswire  bzx international study shows two glaukos istent® trabecular microbypass stents and one topical medication deliver sustained iop reduction  am april    businesswire  bzx glaukos corporation acquires iop sensor system from dose medical  pm april    businesswire  bzx research reports initiation on medical supplies stocks  orasure technologies transenterix glaukos and tandem diabetes  am april    pr newswire  prf glaukos announces fiveyear extensions for three category iii cpt codes related to microinvasive glaucoma surgery  am march    businesswire  bzx glaukos corporation announces fourth quarter  full year  financial results  pm march    businesswire  bzx glaukos technologies featured in eight presentations at  american glaucoma society meeting  pm feb    businesswire  bzx glaukos announces participation in th annual roth conference  am feb    businesswire  bzx how these medical instruments stocks are faring  tandem diabetes care c r bard glaukos and orasure technologies  am feb    pr newswire  prf preeminent ophthalmologist l jay katz joins glaukos corporation as chief medical officer  am feb    businesswire  bzx glaukos completes patient enrollment in pivotal phase of us ide clinical trial for istent supra®  am feb    businesswire  bzx loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pif you suddenly quit your job like sean spicer here’s what you should do next pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders pbanks have raised creditcard interest rates — but not savings account rates aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  glaukos corp  supplier  colombia  import genius plans limited plus premium limitedmonitor your competitors data access data on us ocean freight imports from the last  months for all companies youll have access to data from the previous months from the date of your search we use a rolling date range so you can always look back  months from the current date limitedmonitor your competitors data access data on us ocean freight imports from the last  months for all companies access data on us ocean freight imports from the last  months for all companies youll have access to data from the previous months from the date of your search we use a rolling date range so you can always look back months from the current date plussmall  medium business data access data on us ocean freight imports from the last  months for all companies youll have access to data from the previous months from the date of your search we use a rolling date range so you can always look back months from the current date us ocean freight exports from january   to present for all companies premium empire builder data access data on us ocean freight imports from november  to the present for all companies youll have access to our entire database of shipping manifests of us ocean freight imports going back to november  us ocean freight exports from january   to present for all companies limitedmonitor your competitors usage track the shipping activities of your  chosen companies our limited plan lets you monitor the shipping activities of any three companies across all our databases be the first to know when your target company clears a shipment through customs in one of the countries we track  contact info requests per month our team of account managers and research assistants will help you find contact information for up to  companies in our database each month download csv and xls k records per month if youre planning to do more indepth research on the companies in our database you should upgrade to the plus or premium plans which allow more downloads email alerts for up to  searches if you need to track more than  companies product segments or trade lanes you should upgrade to the plus or premium plan which allow more email alerts limitedmonitor your competitors usage  company searches per day  searches per day may be enough if you are just monitoring a few competitors or researching suppliers in a single industry if youre looking to connect with sales leads or do more indepth research you should upgrade to the plus or premium plan which allows more searches  contact info requests per month our team of account managers and research assistants will help you find contact information for up to  companies in our database each month download csv and xls k records per month if youre planning to do more indepth research on the companies in our database you should upgrade to the plus or premium plan which allow more downloads email alerts for up to  company searches if you need to track more than  companies product segments or trade lanes you should upgrade to the plus or premium plan which allow more email alerts plus small  medium business usage  searches per day  searches per day may be enough if you are just monitoring a few competitors or researching suppliers in a single industry if youre looking to connect with sales leads or do more indepth research you should upgrade to the premium plan which allows more searches  contact info requests per month our team of account managers and research assistants will help you find contact information for up to  companies in our database each month download csv and xls k records per month if youre planning to do more indepth research on the companies in our database you should upgrade to the premium plan which allow more downloads email alerts for up to  searches if you need to track more than  companies product segments or trade lanes you should upgrade to the premium plan which allow more email alerts premium empire builder usage  searches per day    contact info requests per month our team of account managers and research assistants will help you find contact information for up to  companies in our database each month download csv and xls k records per month if youre planning to do more indepth research on the companies in our database contact the sales department to purchase more credits and export additional shipping records email alerts for up to  searches plus small  medium business features visual mapping our visual mapping technology provides an instant snapshot of any companys trade connections navigate the global web of trading partners with the click of a mouse and visualize the relationships between companies many degrees apart premium empire builder features visual mapping our visual mapping technology provides an instant snapshot of any companys trade connections navigate the global web of trading partners with the click of a mouse and visualize the relationships between companies many degrees apart limited monitor your competitors support our customer service agents are available when you need them call in to receive helpful tips and training call or email our customer service agents they will get back to as soon as possible to assist you with your data needs plus small  medium business support our customer service agents are available when you need them call in to receive helpful tips and training call or email our customer service agents they will get back to as soon as possible to assist you with your data needs premium empire builder support our customer service agents are available when you need them call in to receive helpful tips and training call or email our customer service agents they will get back to as soon as possible to assist you with your data needs dedicated research assistant an experienced trade data specialist will serve as your dedicated account manager to locate hardtoreach data perform searches and compile reports on your behalf limited monitor your competitors data access data on us ocean freight imports from the last  months for all companies youll have access to data from the previous months from the date of your search we use a rolling date range so you can always look back  months from the current date x home how it works us data additional countries our datasets our clients ig reviews videos pictures presentation plans  pricing search contact us live chat free demo sign in join now english  french english  french service   sales  live chat choose language english  french hi may i help you with something an importgeniuscom sales agent is available to answer your question chat live now no thanks sign up home how it works plans  pricing search contact us live chat  glaukos corp glaukos corporation is an overseas supplier in united states that exports products to vision partners sas transportation type terrestre call     import genius our bill of lading data reveals the trading activities of glaukos corp and millions of other manufacturers learn more join now request a demo would you like to schedule a free demo wed love to show you international trade data relevant to your own business name email phone schedule a free demo play muted international trade starts with our data other companies in our database legrand france ets normandie virutex ilko sa de cv castillo silvestre juan carlos seasons growers ingenieria estudios y disenos sas view sample shipment records shipment alert subscription contact this company sign up sample shipment record for glaukos corp glaukos corporation is an overseas supplier in united states that exports products to vision partners sas transportation type terrestre bill of lading manufacturer  shipper consignee glaukos corporation  merit cir   laguna hills vision partners sas cr    ap  acquisition destination estados unidos colombia product description cod  dim  do los demas mercancia nueva fabricante glaukos corp con d cod  dim  do los demas mercancia nueva fabricante glaukos corp con d other information available gross weight kg fob usd insurance usd freight usd cif usd brand id operation type arrival datetransportation typeterrestrehs codecustomssanta fe de bogotaquantity  unitu subscribe to access the complete shipping history for glaukos corp join now how will your business use our trade data if youre involved in international trade our database of shipping manifests will help you find opportunities to grow your business find trading partners you can trust monitor competitors shipping activities connect with sales prospects very informative and great site and so quick pretty slick betty fatzie president lab products inc the service was great with a reasonable price and great results we have now started using another supplier from china we just ordered our first container from the new supplier and with the savings it more than paid for the importgeniuscom service on the first container load cleve kurz gifford monument works import genius is not merely an investment for our organization it’s a vital instrument to effectively manage our time it has afforded us the ability to quickly segment target and position ourselves in front of prospective clients thank you import genius david bryant director of business development john s james co import genius data is fantastic for evaluating component manufacturers in china sanjay dastoor boostedboardscom we have confidence that were working with the best manufacturers in part because import genius showed us that they already supply some of the worlds top brands yaniv masjedi vice president nextivacom import genius is a highly informative tool for monitoring public companies operating activities it is an invaluable part of our research eric delamarter managing partner half moon capital we find new clients for our customs brokerage in the importgenius database almost every day jayson gispan customs brokerage operations manager flexportcom importgenius is a great research tool we use it to evaluate manufacturers to make sure we are working with only the highest quality most reliable suppliers chris friedland founder  ceo buildcom importgenius gave us visibility into the actual shipping histories of the manufacturers we were evaluating and helped us feel comfortable we were working with the best suppliers in china morena simitic coo bellabeatcom shipment alert subscription receive free shipment alerts by email whenever glaukos corp clears a shipment through customs processing please wait  submit contact glaukos corp name business email phone submit processing please wait    features save and share reports easily get your searches out of import genius and into your team’s hands for further analysis export your findings to xls or csv or send reports via email it’s the simple things that make our trade data even more valuable to you see the supply chain visual mapping shows you exactly how your target companies and their trading partners connect search by shipper and see everyone they’ve shipped to or search by consignee and see all their suppliers zoom in on any company to see their own trading network dive deep into international trade and discover the links in anyone’s supply chain get realtime shipment alerts stay on top of your competitors suppliers and customers with realtime alerts just set up a search and get an email whenever a new shipment matches your terms import genius lets you know the moment they bring in a rival product or start shipping to a new partner glaukos corp youve viewed  profile pages on import genius which is the most we allow for free sign up for importgenius to get more details on over  million importers and exporters it only takes seconds sign up for import genius plans limited monitor your competitors recommended plan plus small  medium business premium empire builder price    month for  months sign up    month for  months sign up    month for  months sign up data access data on us ocean freight imports from the last  months for all companies view details access data on us ocean freight imports from the last  months for all companies us ocean freight exports from january   to present for all companies view details access data on us ocean freight imports from november  to the present for all companies us ocean freight exports from january   to present for all companies view details usage track the shipping activities of your  chosen companies  contact info requests per month download csv and xls k records per month email alerts for up to  searches view details  searches per day  contact info requests per month download csv and xls k records per month email alerts for up to  searches view details  searches per day  contact info requests per month download csv and xls k records per month email alerts for up to  searches view details features   visual mapping view details visual mapping view details support our customer service agents are available when you need them call in to receive helpful tips and training view details our customer service agents are available when you need them call in to receive helpful tips and training view details our customer service agents are available when you need them call in to receive helpful tips and training dedicated research assistant view details view all us imports instantly search  ocean freight records to monitor us importers research suppliers generate sales leads and more as featured in what is import genius who uses import genius available data fields schedule live demo what is import genius import genius reveals the trading activities of importers and exporters around the world we give you hard data about your overseas suppliers and domestic competitors using shipping databases from customs agencies in the united states latin america and india import genius can help you find reliable new trading partners monitor your competitors’ shipments and keep an eye on your current suppliers and customers our team of seasoned importexport veterans cuttingedge software developers and customer service professionals has worked for years to build the worlds most powerful and accessible database of international trade intelligence we do this for a diverse client base that requires keen insight into international trade our customers include some of the worlds top importers exporters freight forwarders logistics companies manufacturers investment banks financial analysts intellectual property attorneys and more they use our tools to research the trade activity of importers and suppliers identify and vet new sources for any kind of product monitor the competition and their trade connections generate sales leads for transportation and logistics companies track the activity of publiclytraded companies investigate and enforce intellectual property infringement ensure exclusive agent compliance who uses import genius sourcing professionals use our service to view shipping histories for suppliers we provide access to detailed customs records letting you verify suppliers true shipping volumes and us customer lists you can also look up your competing import firms to find where they buy their goods  learn more competitive intelligence analysts use our service to learn where rivals source products we give clear insights into the importing volumes new product releases and broader competitive dynamics of your industry  learn more sales  marketing teams use our service to generate sales prospects we give you the tools to target importers based on product type location shipping volumes and more  learn more financial analysts use our service to monitor public companies imports we offer rare data on the success or failure of new product launches shipping trends and other operating data for companies in any industry  learn more available data fields import genius data fields by collecting the ocean freight bill of lading for all us imports in our database import genius provides unprecedented access to near realtime information on virtually every industry and company importing goods into the country for each shipment entering the us by ocean we provide access to the following information additional fields available for some shipments phone number fax number email contact person list of data fields consigneethe company importing the shipment into the usconsignee addressthe address of the company importing the shipment into the usshipperthe overseas company exporting the shipment to the usshipper addressthe address of the overseas company exporting the shipment to the usproduct descriptionthe exporters description of the shipment as it appears on the bill of lading or shipping manifestgross weightthe gross weight of the shipment excluding the weight of the actual container this can appear in either pounds or kilograms at the discretion of the exporternumber of unitsthe quantity of boxes customs would find if they were to open the shipment for inspectionvolumethe volume of the shipment generally defined in cubic meters or container base measurements cbmarrival datethe date the shipment arrives within the customs territory of the usforeign portthe last port the shipment passes through before arriving in the uscountry of originthe country of the last foreign port the shipment passes through before arriving in the usus portthe us port where the shipment enters the customs territory of the uscarrier codethe four digit standard carrier alpha code of the ocean carrier or freight forwarder managing the transit of the shipmentvoyage numbera unique code assigned to that particular sailing of the ship between two portsvessel namethe name of the ship transporting the shipmentship registered inthe country where the ship is officially registeredbill of lading numberthe unique number assigned to this particular shipment by the ocean carrier or freight forwardercontainer numberthe unique number assigned to the ocean shipping container carrying the shipment in questionmarks  numbersany text or numbers appearing on the cartons ready for a live demo fill out this form and well contact you right away to set up a live demo of import genius schedule live demo processing please wait  name tell us your full name email enter a valid email address phone enter valid phone number preferred date let us know your preferred date preferred time in your country  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  am  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm  pm let us know your preferred time country required timezone required what data are you interested in let us know what you are most interested to learn submit import genius how it works plans  pricing our trade data blog search latin trade data import genius reviews  press coverage who uses import genius contact us latest posts trump properties have… solar panels imports… limited plan now available chilean salmon exports… india us palm oil imports… company profiles barrientos cano hilda mary aceros y servicios del caribe sas jiuh huey enterprise coltd eagleburgmann colombia sas aba air group llc    records in our database and counting customer support team tel  international   fax   infoimportgeniuscom  e pima center pkwy suite  scottsdale az  shanghai china tel  mobile no  fax number  shenzhen china tel  mob  fax  have questions well reply quickly type your info below message submit processing please wait    trainings demos and general contact all available or call us service  sales  back to top all rights reserved copyright   trade data services inc  were offline please leave us a message to chat with a representative of import genius your browser needs to be internet explorer  or higher please fill out the form below and a representative will contact you as soon as possible name email phone message send x glaukos corporation  investors  corporate governance  management team toggle navigation login home»investors»corporate governance»management team login quick links email alerts contact ir rss feeds ethics hotline investor kit management team executive officers thomas w burns    president chief executive officer mr burns has served as our president chief executive officer and as a member of our board of directors since march  mr burns has also been a member of the board of directors of dose medical corporation since october  and served as its chief executive officer and president from march  until june  mr burns has a proven record of building successful medical device and pharmaceutical businesses and creating successful new markets in ophthalmology mr burns has more than  years of direct ophthalmic management experience including over  years of general management experience across a broad range of ophthalmic medical devices ophthalmic pharmaceuticals drug delivery technologies surgical products and overthecounter products prior to joining our company mr burns led eyetech pharmaceuticals inc acquired by osi pharmaceuticals inc as its president and chief operating officer and as a director from  to  mr burns served as senior vice president and general manager of chiron vision corporation acquired by bausch  lomb inc and then as vice president global strategy and general manager refractive surgery of bausch  lomb from  to  mr burns has also served as an entrepreneur in residence at versant ventures management llc an entity affiliated with one of our principal stockholders mr burns received a ba from yale university chris m calcaterra    chief operating officer mr calcaterra has served as our chief operating officer since february  he was previously our chief commercial officer a position he had held since joining glaukos in april  mr calcaterra has more than  years of experience in the ophthalmic medical technology industry prior to joining our company mr calcaterra was senior vice president at advanced medical optics inc acquired by abbott laboratories and was responsible for its cataract business prior to that position mr calcaterra held increasingly responsible vice president positions in a variety of sales and marketing roles at advanced medical optics inc as well as its predecessor surgical division business at allergan inc mr calcaterra has a bs from miami university and an mba from xavier university and he was previously a board member of wavetec vision systems inc acquired by novartis joseph e gilliam    chief financial officer senior vice president corporate development mr gilliam has served as our chief financial officer and senior vice president corporate development since may  he has nearly  years of experience across capital markets strategic advisory finance and banking services with an emphasis on the life sciences industry including the medical technology diagnostics and biotechnology sectors from  to may  he was a managing director in the healthcare investment banking group at jpmorgan where he led the glaukos initial public offering for the firm from  to  mr gilliam held increasingly responsible positions at jpmorgan with experience spanning mergers and acquisitions primary and secondary public equity offerings bank lending bond offerings and other transactions his prior experience includes positions at the beacon group which was combined with jpmorgan and chase manhattan in  and pricewaterhousecoopers mr gilliam has a bs in accounting from the kelly school of business at indiana university key employees robert l davis    senior vice president general counsel robert l davis has served as our senior vice president and general counsel since june  from april  to may  mr davis served as senior vice president general counsel and secretary for targus group international inc a global designer manufacturer and distributor of cases and accessories for mobile electronic devices from december  to april  mr davis served in various executive positions including senior vice president corporate development and assistant general counsel with meade instruments corp a publicly traded designer manufacturer and distributor of precision optical products from september  to december  mr davis was in private legal practice with the law firms of o’melveny  myers llp and morrison  foerster llp mr davis is an active member of the california state bar admitted in  and holds both a ba and a jd from brigham young university jeffrey m wells   pharmd   senior vice president regulatory quality and clinical affairs jeffrey m wells pharmd has served as our senior vice president regulatory quality and clinical affairs since september  prior to joining our company mr wells was senior vice president of product development at bioform medical inc a medical aesthetics firm prior to this mr wells was vice president us research and development at santen pharmaceutical co ltd prior to this role he held various positions with santen including vice president clinical and regulatory affairs and project management for the united states and europe vice president us clinical affairs and director of marketing prior to santen mr wells held various marketing positions with bausch  lomb inc wherehe launched lotemax and several other ophthalmic products mr wells holds a bs and a ba from ohio northern university a masters in management mba from the kellogg graduate school of management at northwestern university and a pharmd from the university of florida mr wells also possesses a regulatory affairs certification michele m allegretto    vice president human resources michele m allegretto has served as our vice president human resources since may  from october  to may  ms allegretto served as director global business human resources with abbott medical optics a global ophthalmic medical device division of abbott laboratories from january  to october  ms allegretto was director of human resources for the wet seal inc a publicly traded national women’s retail chain from april  to december  ms allegretto served in several different leadership positions across three divisions of the walt disney company including the director recruitment for walt disney studios ms allegretto holds a ba from san diego state university and a master’s degree from california state university long beach sheree l aronson    vice president investor relations  corporate marketing sheree l aronson has served as our vice president investor relations and corporate marketing since february  she was previously our vice president investor relations a position she had held since joining glaukos in june  prior to joining glaukos she consulted with various medical technology companies on strategic communications matters from november  to may  ms aronson was vice president of investor relations for masimo corporation a provider of pulse oximetry and noninvasive monitoring technologies from august  to april  ms aronson led the investor relations corporate communications and market research functions at advanced medical optics inc acquired by abbott laboratories her previous experience includes financial communications positions at fleishmanhillard inc apria healthcare mti technology and foodmaker inc ms aronson holds a bs degree in journalism from oklahoma state university david s haffner    senior vice president new technologies david s haffner has served as our senior vice president new technologies since february  he was previously our vice president product development a position he had held since joining glaukos in february  immediately prior to joining our company mr haffner consulted to the medical industry in the areas of medical device and pharmaceutical product development with emphasis on mechanical systems for pharmaceutical drug delivery prior to this he spent over  years at allergan inc leading teams and departments in several divisions including surgical products pharmaceuticals and worldwide operations mr haffner has directed several multimillion dollar programs in both research and development and operations involving development and commercialization of ophthalmic products and technologies targeted at cataract glaucoma dry eye and nasal disease groups the scope of his work has spanned a broad diversity of technical disciplines including operations management process development site construction validation injection molding automated assembly packaging product design engineering analysis and industrial design mr haffner holds a bs from california state university long beach harold a heitzmann   phd   senior vice president applied research  engineering harold a heitzmann has served as our senior vice president applied research and engineering since february  he was previously our vice president applied research a position he had held since joining glaukos in january  he has over  years experience in development of medical devices at five startup companies and at edwards lifesciences corporation including three previous positions as vice president dr heitzmann has led development of commercial products for blood gas monitoring angioplasty intracranial pressure monitoring electrophysiology coronary stenting thrombectomy venous oxygen saturation monitoring and antimicrobial catheterization he holds  issued us patents and has taught at university of california irvine extension in the clinical trials and medical product development certificate programs dr heitzmann holds a ba from cornell university and a phd in molecular biophysics and biochemistry from yale university where he coinvented avidinbiotin staining for microscopy l jay katz   md facs   chief medical officer dr katz has served as our chief medical officer since february  he is currently employed by our company on a parttime basis while maintaining his philadelphiabased ophthalmology practice and involvement in clinical research and medical education dr katz completed his glaucoma fellowship at wills eye hospital in philadelphia in  and has been affiliated with the hospital since that time currently serving as its director of glaucoma service since  he has also served as a professor of ophthalmology at jefferson medical college at thomas jefferson university he is a former member of the board and past treasurer of the american glaucoma society a diplomate and associate examiner for the american board of ophthalmology and a fellow memberatlarge and past president of the philadelphia metro chapter of the american college of surgeons he has published more than  articles in ophthalmic journals and served as an investigator in landmark glaucoma trials including the advanced glaucoma intervention study agis and collaborative initial glaucoma treatment study cigts dr katz completed his residency at yale university and internship at the university of virginia after earning his md from yale university medical school he holds a ba summa cum laude from case western reserve university contact investor relations glaukos corporation  avenida fabricante san clemente ca  telephone  ext  fax  email investorsglaukoscom about us mission  overview management team board of directors scientific advisory board news room healthcare professionals general info international contacts reimbursement login policies  info terms of use  privacy policy  declaration of compliance  dfu  mri information investors investor overview stock information financials  filings corporate governance press releases events  presentations resources  alerts careers contact us investors mobile investor overview stock information financials  filings corporate governance press releases events  presentations resources  alerts healthcare professionals general info international contacts reimbursement login careers contact us glaukos® and istent® are registered trademarks of glaukos corporationall rights reserved  phone  fax   avenida fabricante san clemente ca  powered by q inc  glaukos corp  nysegkos  stock quote  news  thestreet action alerts plus access aapjim cramers best stocks for charitable trust portfoliomost recent trade alert investing rules trading commandments real money access rm rules of investingjim cramers best stocks for  commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use  thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under  top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street glaukos corp gkos follow    nyse  health care jul    pm edt prev close  open  day lowhigh     wk lowhigh    volume k avg volume k exchange nyse shares outstanding m market cap b eps  pe ratio  div  yield na na trade with jim cramer  days free latest news glaukos corporation to release second quarter  financial results after market close on august  combining implantation of glaukos istent inject® trabecular microbypass with topical travoprost provides sustained iop reduction and favorable safety profile according to new study interesting gkos put and call options for august th investors in glaukos corp saw new options become available this week for the august th expiration at stock options channel our yieldboost formula has looked up and down the gkos options chain for the new august th contracts and identified one put and one call contract of particular interest jun    am edt glaukos stock sees short interest expand by  the most recent short interest data has been released for the  settlement date which shows a  share increase in total short interest for glaukos corp  to  an increase of  since  total short interest is just one way to look at short data another metric that we here at dividend channel find particularly useful is the days to cover metric because it considers both the total shares short and the average daily volume of shares traded jun    pm edt glaukos announces participation in william blair growth stock conference glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma today may    pm edt study reveals potential cost efficiency of using two glaukos istent® trabecular microbypass stents to treat elevated iop in glaucoma patients glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma today may    pm edt glaukos corp is now oversold legendary investor warren buffett advises to be fearful when others are greedy and be greedy when others are fearful one way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the relative strength index or rsi which measures momentum on a scale of zero to  may    pm edt ratings changes today thestreet quant ratings provides fair and objective information to help you make educated investing decisions we rate over  stocks daily and provide page pdf reports for each stock these ratings can change daily and todays changes are reflected in the email below if you are looking to checkup on the stocks you currently own or are looking for new ideas you can find our full database of passwordprotected ratings reports in our proprietary ratings screener httpwwwthestreetcomkqrflatstockscreenerhtml upgrades aig alsk gne guid hth lpi nuva pirs qrvo s ttmi downgrades arrs bpmc cone cray efii gil gkos hyh sum initiations none read on to get thestreet quant ratings detailed report may    am edt glaukos corporation announces first quarter  financial results glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma today may    pm edt glaukos completes patient enrollment in phase ii clinical trial for idose™ travoprost intraocular implant in glaucoma patients glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma today may    am edt glaukos announces participation in bank of america merrill lynch  health care conference glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma today may    am edt several surgeon presentations to include glaukos technologies at  american society of cataract and refractive surgery glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma may    am edt glaukos corporation to release first quarter  financial results after market close on may  glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma plans to apr    am edt international study shows two glaukos istent® trabecular microbypass stents and one topical medication deliver sustained iop reduction glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma today apr    am edt glaukos corporation acquires iop sensor system from dose medical glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma today apr    pm edt glaukos announces fiveyear extensions for three category iii cpt codes related to microinvasive glaucoma surgery glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma today mar    am edt ratings changes today thestreet quant ratings provides fair and objective information to help you make educated investing decisions we rate over  stocks daily and provide page pdf reports for each stock these ratings can change daily and todays changes are reflected in the email below if you are looking to checkup on the stocks you currently own or are looking for new ideas you can find our full database of passwordprotected ratings reports in our proprietary ratings screener httpwwwthestreetcomkqrflatstockscreenerhtml upgrades abco aegn avgo gkos gpt gtn mygn sino thrm downgrades an codi prgx tait trec initiations bmch read on to get thestreet quant ratings detailed report mar    am est glaukos corporation announces fourth quarter  full year  financial results glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma today mar    pm est glaukos technologies featured in eight presentations at  american glaucoma society meeting glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma feb    pm est glaukos announces participation in th annual roth conference glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma today feb    am est preeminent ophthalmologist l jay katz joins glaukos corporation as chief medical officer glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma today feb    am est glaukos completes patient enrollment in pivotal phase of us ide clinical trial for istent supra® glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma today feb    am est glaukos corporation to release fourth quarter and full year  financial results after market close on march  glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma plans to feb    am est joseph gilliam to join glaukos corporation as chief financial officer and senior vice president of corporate development glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma today feb    am est glaukos corporation promotes chris m calcaterra to chief operating officer glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma today feb    pm est first week of february th options trading for glaukos gkos investors in glaukos corp saw new options become available this week for the february th expiration at stock options channel our yieldboost formula has looked up and down the gkos options chain for the new february th contracts and identified one put and one call contract of particular interest jan    am est glaukos announces participation in jp morgan healthcare conference glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma today dec    pm est study published in journal of glaucoma evaluates a single glaukos istent® trabecular microbypass stent as a standalone procedure glaukos corporation nyse gkos an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma today dec    am est mad money lightning round chevron american electric power wendys jim cramer likes wen cvx and aep nov    am est jim cramers mad money recap tech and natural resources both gain next phase of this trump rally shows theres money moving in says jim cramer nov    pm est next load more quant rating on  pm edt  d sell get the gkos report here from our partners glaukos istent lowered iop  in openangle glaucoma patients seekingalpha glaukos drops after piper jaffray gets nearterm cautious the fly glaukos gkos bank of america merrill lynch  health care conference  slideshow seekingalpha glaukos longer term outlook remains positive says stifel the fly glaukos recent weakness provides attractive entry point says roth capital the fly update glaukos upgraded to overweight at stephens the fly glaukos upgraded to overweight from equal weight at stephens the fly glaukos outlook remains positive says stifel the fly glaukos quarter better than inline says jpmorgan the fly glaukos quarter likely not enough to keep multiple says piper jaffray the fly glaukos beats by  beats on revenue seekingalpha notable earnings after wednesday’s close seekingalpha glaukos likely to overturn istent rate cut by noridian  wells fargo seekingalpha medicare contractor noridian proposes rate cut for glaukos istent shares slump  seekingalpha glaukos will likely be able to overturn adverse ruling says wells fargo the fly thestreet quant rating d sell get the gkos report here trending walmart in focus amid horrific human trafficking incident in texas that causes nine deaths billionaire mark cuban the rise of technology will cause a lot of unemployment as snap continues to stumble should it consider selling itself chipotle is doomed unless it takes this one dramatic measure trump just resurrected the ugly practice known as civil forfeiture for no reason advertising partners  thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers